Posts Tagged ‘bladder cancer’

June 16th, 2011

FDA Says Pioglitazone Use Is Linked to Bladder Cancer

The FDA has issued a safety announcement stating that the use of pioglitazone (Actos) for more than 1 year may be  associated with increased risk for bladder cancer. The FDA announcement follows last week’s suspension of the drug in France and Germany by regulatory authorities in those countries. The FDA said that pioglitazone should not be […]

June 9th, 2011

Pioglitazone (Actos) Suspended in France Over Cancer Concerns

Sales of the popular diabetes drug pioglitazone (Actos, Takeda) have been suspended in France after a study carried out by the French health insurance fund (CNAM) found that it may increase the risk of bladder cancer. The French regulatory agency (AFSSAPS) said that new prescriptions for drugs containing pioglitazone may no longer be written, but […]